REPORT ID 13307

United States Anemia Therapeutics Market Report 2017

Publish Date
21-Nov-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Anemia Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Anemia Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Anemia Therapeutics market competition by top manufacturers/players, with Anemia Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AMAG Pharmaceuticals
    Daiichi Sankyo
    Galenica
    Pharmacosmos
    Acceleron Pharma
    Bayer
    GlycoMimetics
    GlaxoSmithKline
    Novartis
    Pieris Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Iron
    Folic Acid Class
    Vitamin B12
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Household

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Anemia Therapeutics Market Report 2017
1 Anemia Therapeutics Overview
    1.1 Product Overview and Scope of Anemia Therapeutics
    1.2 Classification of Anemia Therapeutics by Product Category
        1.2.1 United States Anemia Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Anemia Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Iron
        1.2.4 Folic Acid Class
        1.2.5 Vitamin B12
    1.3 United States Anemia Therapeutics Market by Application/End Users
        1.3.1 United States Anemia Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital
        1.3.3 Household
    1.4 United States Anemia Therapeutics Market by Region
        1.4.1 United States Anemia Therapeutics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Anemia Therapeutics Status and Prospect (2012-2022)
        1.4.3 Southwest Anemia Therapeutics Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Anemia Therapeutics Status and Prospect (2012-2022)
        1.4.5 New England Anemia Therapeutics Status and Prospect (2012-2022)
        1.4.6 The South Anemia Therapeutics Status and Prospect (2012-2022)
        1.4.7 The Midwest Anemia Therapeutics Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Anemia Therapeutics (2012-2022)
        1.5.1 United States Anemia Therapeutics Sales and Growth Rate (2012-2022)
        1.5.2 United States Anemia Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Anemia Therapeutics Market Competition by Players/Suppliers
    2.1 United States Anemia Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Anemia Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Anemia Therapeutics Average Price by Players/Suppliers (2012-2017)
    2.4 United States Anemia Therapeutics Market Competitive Situation and Trends
        2.4.1 United States Anemia Therapeutics Market Concentration Rate
        2.4.2 United States Anemia Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Anemia Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anemia Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Anemia Therapeutics Sales and Market Share by Region (2012-2017)
    3.2 United States Anemia Therapeutics Revenue and Market Share by Region (2012-2017)
    3.3 United States Anemia Therapeutics Price by Region (2012-2017)

4 United States Anemia Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Anemia Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Anemia Therapeutics Revenue and Market Share by Type (2012-2017)
    4.3 United States Anemia Therapeutics Price by Type (2012-2017)
    4.4 United States Anemia Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Anemia Therapeutics Sales (Volume) by Application (2012-2017)
    5.1 United States Anemia Therapeutics Sales and Market Share by Application (2012-2017)
    5.2 United States Anemia Therapeutics Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Anemia Therapeutics Players/Suppliers Profiles and Sales Data
    6.1 AMAG Pharmaceuticals
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Anemia Therapeutics Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AMAG Pharmaceuticals Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Daiichi Sankyo
        6.2.2 Anemia Therapeutics Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Daiichi Sankyo Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Galenica
        6.3.2 Anemia Therapeutics Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Galenica Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pharmacosmos
        6.4.2 Anemia Therapeutics Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pharmacosmos Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Acceleron Pharma
        6.5.2 Anemia Therapeutics Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Acceleron Pharma Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Bayer
        6.6.2 Anemia Therapeutics Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Bayer Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 GlycoMimetics
        6.7.2 Anemia Therapeutics Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 GlycoMimetics Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 GlaxoSmithKline
        6.8.2 Anemia Therapeutics Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 GlaxoSmithKline Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Novartis
        6.9.2 Anemia Therapeutics Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Novartis Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Pieris Pharmaceuticals
        6.10.2 Anemia Therapeutics Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Pieris Pharmaceuticals Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Anemia Therapeutics Manufacturing Cost Analysis
    7.1 Anemia Therapeutics Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Anemia Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Anemia Therapeutics Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Anemia Therapeutics Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Anemia Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Anemia Therapeutics Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Anemia Therapeutics Sales Volume Forecast by Type (2017-2022)
    11.3 United States Anemia Therapeutics Sales Volume Forecast by Application (2017-2022)
    11.4 United States Anemia Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer